These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7488277)

  • 21. Polymerized-type I collagen for the treatment of patients with rheumatoid arthritis. Effect of intramuscular administration in a double blind placebo-controlled clinical trial.
    Furuzawa-Carballeda J; Fenutria-Ausmequet R; Gil-Espinosa V; Lozano-Soto F; Teliz-Meneses MA; Romero-Trejo C; Alcocer-Varela J
    Clin Exp Rheumatol; 2006; 24(5):514-20. PubMed ID: 17181919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of health-related quality-of-life measures for rheumatoid arthritis research. The Auranofin Cooperating Group.
    Bombardier C; Raboud J
    Control Clin Trials; 1991 Aug; 12(4 Suppl):243S-256S. PubMed ID: 1663860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Health-related quality of life: validity, reliability, and responsiveness of SF-36, 15D, EQ-5D [corrected] RAQoL, and HAQ in patients with rheumatoid arthritis.
    Linde L; Sørensen J; Ostergaard M; Hørslev-Petersen K; Hetland ML
    J Rheumatol; 2008 Aug; 35(8):1528-37. PubMed ID: 18484697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A simplified disease activity index for rheumatoid arthritis for use in clinical practice.
    Smolen JS; Breedveld FC; Schiff MH; Kalden JR; Emery P; Eberl G; van Riel PL; Tugwell P
    Rheumatology (Oxford); 2003 Feb; 42(2):244-57. PubMed ID: 12595618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and tolerability of valdecoxib in treating the signs and symptoms of severe rheumatoid arthritis: a 12-week, multicenter, randomized, double-blind, placebo-controlled study.
    Gibofsky A; Rodrigues J; Fiechtner J; Berger M; Pan S
    Clin Ther; 2007 Jun; 29(6):1071-85. PubMed ID: 17692722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Magnetic resonance imaging assessed inflammation in the wrist is associated with patient-reported physical impairment, global assessment of disease activity and pain in early rheumatoid arthritis: longitudinal results from two randomised controlled trials.
    Glinatsi D; Baker JF; Hetland ML; Hørslev-Petersen K; Ejbjerg BJ; Stengaard-Pedersen K; Junker P; Ellingsen T; Lindegaard HM; Hansen I; Lottenburger T; Møller JM; Ørnbjerg L; Vestergaard A; Jurik AG; Thomsen HS; Torfing T; Møller-Bisgaard S; Axelsen MB; Østergaard M
    Ann Rheum Dis; 2017 Oct; 76(10):1707-1715. PubMed ID: 28611080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient-reported outcomes from a phase 3 study of baricitinib versus placebo or adalimumab in rheumatoid arthritis: secondary analyses from the RA-BEAM study.
    Keystone EC; Taylor PC; Tanaka Y; Gaich C; DeLozier AM; Dudek A; Zamora JV; Cobos JAC; Rooney T; Bono S; Arora V; Linetzky B; Weinblatt ME
    Ann Rheum Dis; 2017 Nov; 76(11):1853-1861. PubMed ID: 28798049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Health-related quality of life outcomes of adalimumab for patients with early rheumatoid arthritis: results from a randomized multicenter study.
    Strand V; Rentz AM; Cifaldi MA; Chen N; Roy S; Revicki D
    J Rheumatol; 2012 Jan; 39(1):63-72. PubMed ID: 22045836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Self-assessment of disease activity by patients with rheumatoid arthritis.
    Hanly JG; Mosher D; Sutton E; Weerasinghe S; Theriault D
    J Rheumatol; 1996 Sep; 23(9):1531-8. PubMed ID: 8877920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validity of area-under-the-curve analysis to summarize effect in rheumatoid arthritis clinical trials.
    Pham B; Cranney A; Boers M; Verhoeven AC; Wells G; Tugwell P
    J Rheumatol; 1999 Mar; 26(3):712-6. PubMed ID: 10090188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reliability and Validity of the Work Instability Scale for Rheumatoid Arthritis.
    Revicki D; Ganguli A; Kimel M; Roy S; Chen N; Safikhani S; Cifaldi M
    Value Health; 2015 Dec; 18(8):1008-15. PubMed ID: 26686785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Responsiveness of patient reported outcomes including fatigue, sleep quality, activity limitation, and quality of life following treatment with abatacept for rheumatoid arthritis.
    Wells G; Li T; Maxwell L; Maclean R; Tugwell P
    Ann Rheum Dis; 2008 Feb; 67(2):260-5. PubMed ID: 17846044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A pilot study of acupuncture as adjunctive treatment of rheumatoid arthritis.
    Zanette Sde A; Born IG; Brenol JC; Xavier RM
    Clin Rheumatol; 2008 May; 27(5):627-35. PubMed ID: 17989918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A new approach to assessing rheumatoid arthritis (RA) disease activity using the American College of Rheumatology core set of disease activity measures for RA trials--a multi-center study].
    Okano Y; Akizuki M; Kondo H; Kawai S; Suzuki Y; Takeuchi T; Matsuoka Y; Kawaguchi Y; Kashiwazaki S
    Ryumachi; 1997 Jun; 37(3):467-75. PubMed ID: 9256030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. The Methotrexate-Cyclosporine Combination Study Group.
    Tugwell P; Pincus T; Yocum D; Stein M; Gluck O; Kraag G; McKendry R; Tesser J; Baker P; Wells G
    N Engl J Med; 1995 Jul; 333(3):137-41. PubMed ID: 7791814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluating the Effect of Oral N-acetylcysteine as an Adjuvant Treatment on Clinical Outcomes of Patients with Rheumatoid Arthritis: A Randomized, Double Blind Clinical Trial.
    Batooei M; Tahamoli-Roudsari A; Basiri Z; Yasrebifar F; Shahdoust M; Eshraghi A; Mehrpooya M; Ataei S
    Rev Recent Clin Trials; 2018; 13(2):132-138. PubMed ID: 29521247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dose response and safety study of meloxicam up to 22.5 mg daily in rheumatoid arthritis: a 12 week multicenter, double blind, dose response study versus placebo and diclofenac.
    Furst DE; Kolba KS; Fleischmann R; Silverfield J; Greenwald M; Roth S; Hall DB; Roszko PJ;
    J Rheumatol; 2002 Mar; 29(3):436-46. PubMed ID: 11908554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Most patients receiving routine care for rheumatoid arthritis in 2001 did not meet inclusion criteria for most recent clinical trials or american college of rheumatology criteria for remission.
    Sokka T; Pincus T
    J Rheumatol; 2003 Jun; 30(6):1138-46. PubMed ID: 12784382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patient-reported outcomes from a randomized phase III trial of sarilumab monotherapy versus adalimumab monotherapy in patients with rheumatoid arthritis.
    Strand V; Gossec L; Proudfoot CWJ; Chen CI; Reaney M; Guillonneau S; Kimura T; van Adelsberg J; Lin Y; Mangan EK; van Hoogstraten H; Burmester GR
    Arthritis Res Ther; 2018 Jun; 20(1):129. PubMed ID: 29921318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preliminary evaluation of a visual analog function scale for use in rheumatoid arthritis.
    Wolfe F; Michaud K; Pincus T
    J Rheumatol; 2005 Jul; 32(7):1261-6. PubMed ID: 15996062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.